Nature Biotechnology 24, 5 (2006)
Published online: 5 January 2006; | doi:10.1038/nbt0106-5
Serono changes tackCormac Sheridan
Dublin
What appears to be Serono's imminent departure from the ranks of biotech, could be another phase in the maturation of the continent's pharmaceutical sector.
|
